GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » Price-to-Owner-Earnings

Shanghai HeartCare Medical Technology (HKSE:06609) Price-to-Owner-Earnings : (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology Price-to-Owner-Earnings?

As of today (2024-06-07), Shanghai HeartCare Medical Technology's share price is HK$16.88. Shanghai HeartCare Medical Technology does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings or its related term are showing as below:


HKSE:06609's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 31.965
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-07), Shanghai HeartCare Medical Technology's share price is HK$16.88. Shanghai HeartCare Medical Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-2.70. Therefore, Shanghai HeartCare Medical Technology's PE Ratio for today is At Loss.

As of today (2024-06-07), Shanghai HeartCare Medical Technology's share price is HK$16.88. Shanghai HeartCare Medical Technology's EPS without NRI for the trailing twelve months (TTM) ended in was HK$-2.45. Therefore, Shanghai HeartCare Medical Technology's PE Ratio without NRI for today is At Loss.


Shanghai HeartCare Medical Technology Price-to-Owner-Earnings Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology Price-to-Owner-Earnings Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - -

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings falls into.



Shanghai HeartCare Medical Technology Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=16.88/-3.44
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai HeartCare Medical Technology  (HKSE:06609) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Shanghai HeartCare Medical Technology Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines